Newton Biocapital II

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Deloitte R\u00E9viseurs d\u0027Entreprise",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": "0429.053.863",
        "name": "Deloitte R\u00E9viseurs d\u0027Entreprise",
        "address": "1930 Zaventem, A\u00E9roport National de Bruxelles IJ",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Ordinaire d\u00E9cide de renouveler le mandat de Deloitte R\u00E9viseurs d\u0027Entreprise, ayant son si\u00E8ge \u00E0 1930 Zaventem, A\u00E9roport National de Bruxelles IJ et inscrit aupr\u00E8s de la BCE sous le num\u00E9ro d\u0027entreprise 0429.053.863, ayant comme repr\u00E9sentant permanent Mme Julie Delforge, en tant qu",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 3
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Laurent Verhavert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Strelia",
        "address": "1000 Bruxelles, rue Royale 145",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Ordinaire procuration \u00E0 Laurent Verhavert et Elisa Servais, ou tout autre avocat ou employ\u00E9 du cabinet d\u0027avocats Strelia, dont les bureaux sont situ\u00E9s \u00E0 1000 Bruxelles, rue Royale 145, chacun agissant individuellement, avec droit de substitution, afin d\u0027accomplir toutes les form",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Elisa Servais",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Strelia",
        "address": "1000 Bruxelles, rue Royale 145",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale Ordinaire procuration \u00E0 Laurent Verhavert et Elisa Servais, ou tout autre avocat ou employ\u00E9 du cabinet d\u0027avocats Strelia, dont les bureaux sont situ\u00E9s \u00E0 1000 Bruxelles, rue Royale 145, chacun agissant individuellement, avec droit de substitution, afin d\u0027accomplir toutes les form",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Derruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-09-03",
    "filing_date": "2025-08-27",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-05-27",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0779.335.513",
    "name_full": "Newton Biocapital II",
    "legal_form": "SA",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Strelia",
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-10-04",
    "filing_date": "2024-10-02",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-09-29",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "targeted_amendment",
      "legal_form_change",
      "wvv_adaptation",
      "name_change",
      "object_change",
      "duration_change",
      "share_split",
      "share_consolidation",
      "share_class_creation",
      "language_switch",
      "warrant_exercise_capital_update",
      "board_authorized_capital",
      "governance_restructure",
      "liquidation_preference_introduction",
      "seat_region_change",
      "other"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "fr"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0779.335.513",
    "name_full_after": "Newton Biocapital II",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "Newton Biocapital II",
    "current_zetel_raw": "Avenue de Tervueren 273 1150 Woluwe-Saint-Pierre",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Remplacement du texte de l\u0027article 6 d\u00E9finissant le capital et ses actions.",
      "new_text": "Article 6. Capital\n6.1. Le capital est fix\u00E9 \u00E0 cinquante-trois millions cent douze mille onze euros (EUR 53.112.011).\n6.2. Il est repr\u00E9sent\u00E9 par 53.164.556 actions sans valeur nominale, dont 52.632.911 Actions de\nClasse A et 531.645 Actions de Classe B, repr\u00E9sentant chacune une part \u00E9gale du capital.",
      "change_kind": "replaced",
      "article_title": "Capital",
      "article_number": "6"
    },
    {
      "summary": "Remplacement du texte de l\u0027article 8 d\u00E9taillant les classes d\u0027actions et leurs droits.",
      "new_text": "Article 8. Classes d\u0027Actions\n8.1. Lors de la constitution de la Soci\u00E9t\u00E9, les Actions ont \u00E9t\u00E9 divis\u00E9es en deux (2) classes, \u00E0 savoir\nles Actions de Classe A et les Actions de Classe B:\n(i) Il existe cinquante-deux millions six cent trente-deux mille neuf cent onze (52.632.911) Actions de\n(ii) Il existe cinq cent trente et un mille six cent quarante-cinq (531.645) Actions de Classe B.\n8.2. Sauf disp",
      "change_kind": "replaced",
      "article_title": "Classes d\u0027Actions",
      "article_number": "8"
    },
    {
      "summary": "Modification de l\u0027article 23.1 pour fixer l\u0027heure de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire.",
      "new_text": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale ordinaire se r\u00E9unit le quatri\u00E8me mardi du mois de mai \u00E0 9:30 heures. Si ce\njour est un jour f\u00E9ri\u00E9, l\u0027Assembl\u00E9e G\u00E9n\u00E9rale ordinaire a lieu le Jour Ouvrable suivant.",
      "change_kind": "replaced",
      "article_title": null,
      "article_number": "23.1"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "onze procurations",
    "le texte coordonn\u00E9 des statuts",
    "le rapport pr\u00E9par\u00E9 par le conseil d\u0027administration",
    "le rapport pr\u00E9par\u00E9 par le commissaire aux articles 7:155 et 7:179 du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": true,
    "liquidation_preference_text": null,
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": true
  },
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_decrease",
      "share_class_creation",
      "share_class_merge",
      "capital_increase_cash",
      "share_class_merge",
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": 53164556,
    "shares_before": 15596969,
    "capital_after_eur": 53112011.0,
    "capital_before_eur": 15598443.0,
    "share_classes_after": [
      {
        "count": 52632911,
        "label": "Classe A",
        "rights_summary": "Repr\u00E9sentent chacune une part \u00E9gale du capital.",
        "voting_per_share": null
      },
      {
        "count": 531645,
        "label": "Classe B",
        "rights_summary": "Repr\u00E9sentent chacune une part \u00E9gale du capital.",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "rep_rotation",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Sophie Sauvage",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": {
        "kbo": null,
        "name": "Sparaxis SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "M. Philippe Degive, repr\u00E9sentant de Sparaxis SA, Administrateur, informe le Conseil d\u0027administration de la Soci\u00E9t\u00E9 que Mme Sophie Sauvage le remplacera en cette qualit\u00E9 avec effet imm\u00E9diat.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": "Sophie Sauvage",
      "rep_rotation_old_rep": "Philippe Degive",
      "effective_date_qualifier": "immediate"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-02-09",
    "filing_date": "2023-03-28",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2023-03-28",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0779.335.513",
    "name_full": "Newton Biocapital I",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Elisabeth Bousmar",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire sp\u00E9cial"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 15598443.0,
      "delta_eur": 2626262.0,
      "before_eur": 12972181.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 2626262,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 1.0
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 2626262.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-10-17",
    "filing_date": "2023-10-13",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-09-29",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0779.335.513",
    "name_full": "Newton Biocapital II",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procurations",
    "rapport du conseil d\u2019administration",
    "rapport du commissaire",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 15441002,
      "class_name": "Classe A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 155967,
      "class_name": "Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 4886965.0,
      "delta_eur": -163540.0,
      "before_eur": 5050505.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 12961596.0,
      "delta_eur": 8074631.0,
      "before_eur": 4886965.0,
      "share_emission": {
        "agio_eur": 10585.0,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 8074631,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 1.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 8074631.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "agio_incorporation",
      "after_eur": 12972181.0,
      "delta_eur": 10585.0,
      "before_eur": 12961596.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-12-21",
    "filing_date": "2022-12-19",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-12-15",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0779.335.513",
    "name_full": "Newton Biocapital II",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procurations",
    "rapport du conseil d\u0027administration",
    "rapport du commissaire",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 12841002,
      "class_name": "Classe A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 129705,
      "class_name": "Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Alain Parthoens",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": {
        "kbo": "0767.828.541",
        "name": "Newton Biocapital II Partners SRL",
        "address": "Avenue de Tervueren 273, 1150 Woluwe-Saint-Pierre",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "le conseil d\u0027administration de la Soci\u00E9t\u00E9 d\u00E9cide de nommer la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022Newton Biocapital Il Partners\u0022, ayant son si\u00E8ge \u00E0 Avenue de Tervueren 273, 1150 Woluwe-Saint-Pierre, avec num\u00E9ro d\u0027entreprise 0767.828.541, et dont le repr\u00E9sentant permanent est Monsieur Alain Parthoens [",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Alain Parthoens",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": {
        "kbo": "0767.828.541",
        "name": "Newton Biocapital II Partners SRL",
        "address": "Avenue de Tervueren 273, 1150 Woluwe-Saint-Pierre",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "En outre, le conseil d\u0027administration de la Soci\u00E9t\u00E9 d\u00E9cide de d\u00E9l\u00E9guer les pouvoirs sp\u00E9c\u00EDaux suivants \u00E0 Newton Biocapital II Partners SRL, repr\u00E9sent\u00E9e par Monsieur Alain Parthoens, agissant en tant que d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re de la Soci\u00E9t\u00E9",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2022-09-08",
    "filing_date": "2022-02-19",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2022-02-19",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0779.335.513",
    "name_full": "NEWTON BIOCAPITAL II",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Vincent LONGUEVILLE",
    "org_rep_person_name": null,
    "person_role_at_subject": "mandataire"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}